OXYCODONE AND ASPIRIN (HALF-STRENGTH) Drug Patent Profile
✉ Email this page to a colleague
When do Oxycodone And Aspirin (half-strength) patents expire, and what generic alternatives are available?
Oxycodone And Aspirin (half-strength) is a drug marketed by Roxane and is included in one NDA.
The generic ingredient in OXYCODONE AND ASPIRIN (HALF-STRENGTH) is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXYCODONE AND ASPIRIN (HALF-STRENGTH)?
- What are the global sales for OXYCODONE AND ASPIRIN (HALF-STRENGTH)?
- What is Average Wholesale Price for OXYCODONE AND ASPIRIN (HALF-STRENGTH)?
Summary for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 6 |
| DailyMed Link: | OXYCODONE AND ASPIRIN (HALF-STRENGTH) at DailyMed |
-patent-expirations.png "OXYCODONE AND ASPIRIN (HALF-STRENGTH) drug patent expirations")
Recent Clinical Trials for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of North Carolina, Chapel Hill | Phase 4 |
| Albany Medical College | Phase 4 |
| John Mascarenhas | Phase 1 |
See all OXYCODONE AND ASPIRIN (HALF-STRENGTH) clinical trials
US Patents and Regulatory Information for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roxane | OXYCODONE AND ASPIRIN (HALF-STRENGTH) | aspirin; oxycodone hydrochloride; oxycodone terephthalate | TABLET;ORAL | 087742-001 | Jun 4, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
